Navigation Links
Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
Date:7/9/2008

US Office Relocation to California

MELBOURNE, Australia, July 10 /PRNewswire/ -- Cytopia (ASX: CYT) announced today the appointment of Dr. Devron Averett as Chief Scientific Advisor to the company.

Based in California, USA, Dr. Averett will work closely with the company's executive management team, on a part-time basis during this year, to provide scientific leadership and guidance. He has held global leadership roles at Glaxo Wellcome and Burroughs Wellcome and in recent years, at Valeant Pharmaceuticals International and Anadys Pharmaceuticals, Inc, a company he co-founded.

Holding a Ph.D. in Microbiology and Immunology, Dr. Averett has authored or coauthored over 40 peer-reviewed publications and numerous presentations. He is an inventor on 17 issued and nine pending US patents, and their corresponding international filings. His work has contributed to the discovery or development of multiple oncology and antiviral medicines and drug candidates, including Zeffix, Emtriva, Ziagen, Arranon, and most recently ANA598 for HCV and ANA773 in oncology.

"We are extremely pleased to have secured the services of Dr. Averett," said Cytopia CEO, Mr. Andrew Macdonald. "His contribution will bolster the work currently underway on our range of small molecule compounds that are both approaching the clinic and progressing through clinical trials."

Cytopia Inc is consolidating its North American operations in Woodside, California and closing the Rensselaer, New York office, which is currently led by Dr. Shreefal Mehta as VP Business and Corporate Development. Dr. Mehta has chosen not to relocate to the West Coast and will leave Cytopia Inc at the end of July, 2008. The company is grateful for his considerable contributions.

Mr. Richard Haiduck, who has been working with the company in a strategic consulting role, has been appointed as Chief Business Advisor, with responsibility for Cytopia's global business and corporate development. Mr. Haiduck has over 25 years of extensive experience with prominent life sciences companies, including Abbott, Geron, Desmos, and BioStreet, and most recently as Managing Director in the Merchant Banking Group of Burrill & Company. He has an undergraduate degree in Marketing and an MBA in Finance.

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and drug development through subsidiaries based in Melbourne, Australia and San Francisco, USA and specializes in developing new small molecule compounds with an improved therapeutic profile for the treatment of cancer.

The lead program for the company is CYT997, a vascular disrupting agent (VDA) for the treatment of various cancers, and currently being trialed in Phase 1 and Phase 2 clinical studies. Cytopia also is building on its range of JAK inhibitors and kinase expertise, with CYT387, a novel oral JAK2 inhibitor focused on the treatment of myeloproliferative disorders, expected to enter Phase 1 clinical studies in early 2009.

Website: http://www.cytopia.com.au


'/>"/>
SOURCE Cytopia
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
2. Cell Biosciences Strengthens Management Team
3. DuPont Strengthens Commitment to Responsible Science with New Biotech Advisory Panel Members
4. Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions
5. Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement
6. GeoVax Further Strengthens Management Team
7. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
8. SpectraScience Strengthens Leadership Team With Four Key Hires
9. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 ... London (ICR) and University of ... prognostic tool to risk-stratify patients with multiple myeloma (MM), in ... nine . The University of Leeds ... by Myeloma UK, and ICR will perform the testing services ...
(Date:10/10/2017)... ... , ... San Diego-based team building and cooking events company, Lajollacooks4u, has unveiled ... bold new look is part of a transformation to increase awareness, appeal to new ... , It will also expand its service offering from its signature gourmet cooking classes ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:3/29/2017)... March 29, 2017  higi, the health IT company ... North America , today announced a Series ... acquisition of EveryMove. The new investment and acquisition accelerates ... tools to transform population health activities through the collection ... higi collects and secures data today on ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global ... to 2025" report to their offering. ... The Global Biometric Vehicle Access System Market ... the next decade to reach approximately $1,580 million by 2025. ... for all the given segments on global as well as regional ...
Breaking Biology News(10 mins):